• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday

    4/3/24 10:31:14 AM ET
    $ALTM
    $ATAI
    $CALM
    $ESPR
    Major Chemicals
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ALTM alert in real time by email

    U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday.

    Shares of Signet Jewelers Limited (NYSE:SIG) rose sharply during Wednesday’s session after the company raised its FY25 guidance.

    The company and Leonard Green & Partners, L.P., an equity investment firm, today announced the amendment of the terms of the Series A Convertible Preference Shares to net share settlement and the repurchase of half of the Preferred Shares.
    Signet increased its FY25 adjusted EPS outlook to $9.90 – $11.52 from $9.08 – $10.48 versus an estimate of $9.72.

    Signet Jewelers shares surged 9.2% to $103.80 on Wednesday.

    Here are some other big stocks recording gains in today’s session.

    • Destiny Tech100 Inc. (NYSE:DXYZ) shares jumped 21.4% to $25.77.
    • Ocugen, Inc. (NASDAQ:OCGN) shares gained 14.2% to $1.5750. HC Wainwright & Co. analyst Swayampakula Ramakanth reiterated Ocugen with a Buy and maintained a $7 price target.
    • Pyxis Oncology, Inc. (NASDAQ:PYXS) rose 12.3% to $6.04.
    • Atai Life Sciences N.V. (NASDAQ:ATAI) climbed 11.4% to $2.08. Maxim Group analyst Jason McCarthy upgraded ATAI Life Sciences from Hold to Buy and announced a $6 price target.
    • SolarMax Technology, Inc. (NASDAQ:SMXT) rose 10.4% to $11.85.
    • Dave & Buster's Entertainment, Inc. (NASDAQ:PLAY) shares gained 10.2% to $68.22 after the company reported fourth quarter results.
    • Esperion Therapeutics, Inc. (NASDAQ:ESPR) gained 9.7% to $3.16.
    • TransMedics Group, Inc. (NASDAQ:TMDX) rose 9.2% to $79.47.
    • Porch Group, Inc. (NASDAQ:PRCH) gained 8.3% to $4.3450. Cantor Fitzgerald analyst Josh Siegler maintained Porch Group with an Overweight and raised the price target from $3 to $5.
    • ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) gained 7.7% to $10.95.
    • Semtech Corporation (NASDAQ:SMTC) climbed 7.4% to $30.28.
    • Cal-Maine Foods, Inc. (NASDAQ:CALM) shares gained 6.8% to $62.88 after the company reported upbeat results for its fourth quarter.
    • Glaukos Corporation (NYSE:GKOS) rose 6.8% to $95.59. Glaukos received permanent J-code for iDose® TR (travoprost intracameral implant).
    • Blue Owl Capital Inc. (NYSE:OWL) gained 6.4% to $19.69 after the company announced a purchase agreement to acquire Kuvare Insurance Services LP for $750 million.
    • B. Riley Financial, Inc. (NASDAQ:RILY) rose 6.3% to $23.88.
    • U.S. Silica Holdings, Inc. (NYSE:SLCA) gained 6.2% to $13.47.
    • Spotify Technology S.A. (NYSE:SPOT) rose 5.6% to $284.61 on reports the company will raise monthly prices.
    • Arcadium Lithium plc (NASDAQ:ALTM) gained 4.8% to $4.34. Raymond James upgraded the stock from Outperform to Strong Buy and maintained its $9 price target.

     

    Now Read This: How To Earn $500 A Month From Levi Strauss Stock Ahead Of Q1 Earnings Report

    Get the next $ALTM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALTM
    $ATAI
    $CALM
    $ESPR

    CompanyDatePrice TargetRatingAnalyst
    Spotify Technology S.A.
    $SPOT
    4/13/2026$630.00Overweight
    Morgan Stanley
    AtaiBeckley Inc.
    $ATAI
    3/27/2026$12.00Buy
    Deutsche Bank
    Spotify Technology S.A.
    $SPOT
    3/26/2026$535.00Outperform
    Daiwa Securities
    Ocugen Inc.
    $OCGN
    3/17/2026$12.00Buy
    Canaccord Genuity
    Ocugen Inc.
    $OCGN
    3/11/2026$10.00Outperform
    Oppenheimer
    Blue Owl Capital Inc.
    $OWL
    3/2/2026$11.00Overweight → Equal Weight
    Barclays
    Spotify Technology S.A.
    $SPOT
    2/26/2026$586.00Neutral → Buy
    Arete
    Blue Owl Capital Inc.
    $OWL
    2/24/2026$10.00Buy → Hold
    Deutsche Bank
    More analyst ratings

    $ALTM
    $ATAI
    $CALM
    $ESPR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-16) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:30 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-17) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:37 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLETOL issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLETOL (SUPPL-13) with active ingredient BEMPEDOIC ACID has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211616, Application Classification: Efficacy

    3/25/24 4:41:29 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALTM
    $ATAI
    $CALM
    $ESPR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Morgan Stanley resumed coverage on Spotify with a new price target

    Morgan Stanley resumed coverage of Spotify with a rating of Overweight and set a new price target of $630.00

    4/13/26 9:01:02 AM ET
    $SPOT
    Broadcasting
    Consumer Discretionary

    Deutsche Bank initiated coverage on AtaiBeckley with a new price target

    Deutsche Bank initiated coverage of AtaiBeckley with a rating of Buy and set a new price target of $12.00

    3/27/26 8:46:10 AM ET
    $ATAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Daiwa Securities initiated coverage on Spotify with a new price target

    Daiwa Securities initiated coverage of Spotify with a rating of Outperform and set a new price target of $535.00

    3/26/26 8:51:46 AM ET
    $SPOT
    Broadcasting
    Consumer Discretionary

    $ALTM
    $ATAI
    $CALM
    $ESPR
    SEC Filings

    View All

    SEC Form PRER14A filed by Ocugen Inc.

    PRER14A - Ocugen, Inc. (0001372299) (Filer)

    4/20/26 5:18:21 PM ET
    $OCGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 144 filed by AtaiBeckley Inc.

    144 - AtaiBeckley Inc. (0002081043) (Subject)

    4/20/26 4:34:27 PM ET
    $ATAI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEF 14A filed by Blue Owl Capital Inc.

    DEF 14A - BLUE OWL CAPITAL INC. (0001823945) (Filer)

    4/17/26 5:15:09 PM ET
    $OWL
    Investment Managers
    Finance

    $ALTM
    $ATAI
    $CALM
    $ESPR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Chief Legal Officer Rodriguez Rodolfo Jr bought $14,673 worth of shares (730 units at $20.10), increasing direct ownership by 5% to 14,500 units (SEC Form 4)

    4 - Dave & Buster's Entertainment, Inc. (0001525769) (Issuer)

    1/20/26 4:30:17 PM ET
    $PLAY
    Restaurants
    Consumer Discretionary

    Co-Chief Executive Officer Ostrover Douglas I bought $2,379,469 worth of Class A Shares (158,000 units at $15.06) (SEC Form 4)

    4 - BLUE OWL CAPITAL INC. (0001823945) (Issuer)

    12/3/25 5:12:45 PM ET
    $OWL
    Investment Managers
    Finance

    Co-Chief Executive Officer Lipschultz Marc S bought $2,379,469 worth of Class A Shares (158,000 units at $15.06) (SEC Form 4)

    4 - BLUE OWL CAPITAL INC. (0001823945) (Issuer)

    12/3/25 5:10:40 PM ET
    $OWL
    Investment Managers
    Finance

    $ALTM
    $ATAI
    $CALM
    $ESPR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Wooley Dudley D

    4 - CAL-MAINE FOODS INC (0000016160) (Issuer)

    4/20/26 4:21:33 PM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    SEC Form 4 filed by Klohn Steve

    4 - Dave & Buster's Entertainment, Inc. (0001525769) (Issuer)

    4/17/26 4:30:06 PM ET
    $PLAY
    Restaurants
    Consumer Discretionary

    SEC Form 4 filed by Ehrlichman Matt

    4 - Porch Group, Inc. (0001784535) (Issuer)

    4/16/26 5:35:36 PM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    $ALTM
    $ATAI
    $CALM
    $ESPR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Sila Realty Trust to be Acquired by Affiliates of Blue Owl for $2.4 Billion

    Sila Realty Trust, Inc. (NYSE:SILA) ("Sila", the "Company") and certain affiliates of Blue Owl Capital Inc. (NYSE:OWL) ("Blue Owl") today announced that Sila has entered into a definitive merger agreement pursuant to which certain affiliates of Blue Owl Real Estate Capital LLC will acquire all outstanding shares of common stock of Sila Realty Trust, Inc. for $30.38 per share in an all-cash transaction valued at approximately $2.4 billion. The purchase price represents a 19.0% premium to Sila's closing stock price of $25.53 on April 17, 2026, the last full trading day prior to the transaction announcement and a 25.6% premium to the 30-trading day volume-weighted average price. "I am extr

    4/20/26 8:30:00 AM ET
    $OWL
    $SILA
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate

    BRC Group Holdings Seeks to Repurchase Minority Shares of B. Riley Securities and Combine B. Riley Securities with B. Riley Wealth

    Transaction Expected to Create a Differentiated Capital Solution for the Small-Cap and Middle MarketLOS ANGELES, April 20, 2026 /PRNewswire/ -- BRC Group Holdings, Inc. (NASDAQ:RILY) ("BRCGH" or the "Company"), a diversified holding company, today announced a series of strategic actions designed to consolidate its financial services platform, and posture the company for renewed growth while reinforcing its position as a leading, end-to-end capital markets and advisory partner serving the small-cap and middle market. The Company intends to repurchase the outstanding shares of B. Riley Securities ("BRS") and seeks to combine BRS with B. Riley Wealth ("BRW"), bringing together the Company's ins

    4/20/26 8:01:00 AM ET
    $RILY
    Investment Managers
    Finance

    Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026

    Mouse analog of MICVO (maMICVO) monotherapy produced dose-dependent inhibition of tumor growth in a syngeneic preclinical model of HNSCC maMICVO monotherapy modulated the tumor-immune environment in a syngeneic preclinical model of HNSCC toward a more favorable immune-permissive environment for immunotherapy maMICVO in combination with anti-mouse PD-1 worked synergistically to produce greater anti-tumor activity compared with either treatment alone in an immune-refractory syngeneic preclinical model of HNSCC Preclinical findings support the ongoing clinical development of MICVO as both monotherapy and in combination with pembrolizumab for R/M HNSCC BOSTON, April 17, 2026 (GLOBE NEWSWIR

    4/17/26 4:05:00 PM ET
    $PYXS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALTM
    $ATAI
    $CALM
    $ESPR
    Leadership Updates

    Live Leadership Updates

    View All

    Cal-Maine Foods Welcomes Dudley D. Wooley to Board of Directors

    RIDGELAND, Miss., April 01, 2026 (GLOBE NEWSWIRE) -- Cal-Maine Foods, Inc. (NASDAQ:CALM), the largest egg company in the United States and a leading player in the egg-based food industry, today announced the appointment of Dudley D. Wooley to its Board of Directors. Mr. Wooley brings extensive leadership experience in risk management, business strategy, and governance, further strengthening the Board's depth of expertise as the Company continues executing its long-term growth strategy. Mr. Wooley currently serves as Chief Executive Officer of Ross & Yerger Insurance, Inc., a super-regional, employee-owned independent insurance agency headquartered in Jackson, Mississippi. With more than t

    4/1/26 6:00:00 AM ET
    $CALM
    Farming/Seeds/Milling
    Consumer Staples

    Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

    Completed target enrollment in Phase 1 monotherapy dose expansion study of micvotabart pelidotin (MICVO) in 2L+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) in the first quarter of 2026 Updated data from MICVO Phase 1 monotherapy study in 2L+ R/M HNSCC on track for mid-year 2026; to include patients treated with modified weight-based dosing and patients treated with total body weight dosing Updated data from MICVO Phase 1/2 dose escalation study in combination with KEYTRUDA® in 1L/2L+ R/M HNSCC on track for the second half of 2026 Announced appointment of Thomas Civik as Interim Chief Executive Officer Expected cash runway into the fourth quarter of 2026 BOSTO

    3/23/26 7:00:00 AM ET
    $PYXS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ZIM Updates on Withholding Tax Procedures on March 2026 Cash Dividend

    HAIFA, Israel, March 19, 2026 /PRNewswire/ -- ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) ("ZIM" or the "Company"), a global container liner shipping company, hereby updates that in connection with the dividend distribution expected to take place on March 26, 2026, as previously announced by the Company on March 9, 2026 (the "Dividend"), the previously obtained tax ruling from the Israeli Tax Authority ("ITA") on tax withholding procedures relating to the payment of the Dividend to the Company's shareholders (the "Ruling"), as extended, shall apply.   As a result of the Ruling, certain shareholders of the Company ("Shareholders") may be eligible to a reduced Israeli withholding tax rate

    3/19/26 7:00:00 AM ET
    $ZIM
    Marine Transportation
    Consumer Discretionary

    $ALTM
    $ATAI
    $CALM
    $ESPR
    Financials

    Live finance-specific insights

    View All

    Sila Realty Trust to be Acquired by Affiliates of Blue Owl for $2.4 Billion

    Sila Realty Trust, Inc. (NYSE:SILA) ("Sila", the "Company") and certain affiliates of Blue Owl Capital Inc. (NYSE:OWL) ("Blue Owl") today announced that Sila has entered into a definitive merger agreement pursuant to which certain affiliates of Blue Owl Real Estate Capital LLC will acquire all outstanding shares of common stock of Sila Realty Trust, Inc. for $30.38 per share in an all-cash transaction valued at approximately $2.4 billion. The purchase price represents a 19.0% premium to Sila's closing stock price of $25.53 on April 17, 2026, the last full trading day prior to the transaction announcement and a 25.6% premium to the 30-trading day volume-weighted average price. "I am extr

    4/20/26 8:30:00 AM ET
    $OWL
    $SILA
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate

    Porch Group to Release First Quarter 2026 Earnings on April 28, 2026

    Porch Group, Inc. ("Porch") (NASDAQ:PRCH), a new kind of homeowners insurance company, announced today it will report financial results for the first quarter ended March 31, 2026, after markets close on Tuesday, April 28, 2026. Q1'26 Earnings Conference Call Porch management will host a live webinar on Tuesday, April 28, 2026, at 5:00 p.m. Eastern (2:00 p.m. Pacific) to discuss financial results and outlook, with a Q&A session to follow. Supporting materials, including a presentation, press release, and additional financial info, will be available on the company's website. All are invited to listen to the event live by registering for the webinar here. A webinar replay will also be av

    4/16/26 9:00:00 AM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    Blue Owl Capital Inc. to Announce First Quarter 2026 Results

    NEW YORK, April 9, 2026 /PRNewswire/ -- Blue Owl Capital Inc. (NYSE:OWL) ("Blue Owl") today announced it will release its financial results for the first quarter ended March 31, 2026 on Thursday, April 30, 2026 before market open. Blue Owl invites all interested persons to its webcast / conference call at 10 a.m. Eastern Time to discuss its results. Conference Call Information:The conference call will be broadcast live on the Shareholders section of Blue Owl's website at www.blueowl.com.Participants are also invited to access the conference call by dialing one of the following numbers:Domestic (Toll Free): +1 (888) 330-2454International: +1 (240) 789-2714Conference ID: 4153114All callers wil

    4/9/26 8:00:00 AM ET
    $OWL
    Investment Managers
    Finance

    $ALTM
    $ATAI
    $CALM
    $ESPR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by ZIM Integrated Shipping Services Ltd.

    SC 13G - ZIM Integrated Shipping Services Ltd. (0001654126) (Subject)

    11/14/24 6:36:01 PM ET
    $ZIM
    Marine Transportation
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by B. Riley Financial Inc.

    SC 13D/A - B. Riley Financial, Inc. (0001464790) (Filed by)

    11/14/24 5:30:03 PM ET
    $RILY
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Blue Owl Capital Inc.

    SC 13G/A - BLUE OWL CAPITAL INC. (0001823945) (Subject)

    11/14/24 5:24:34 PM ET
    $OWL
    Investment Managers
    Finance